CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8+ T cell antitumor immunity
Mariela A. Moreno Ayala(University of California, Berkeley), Michel DuPage(University of California, Berkeley)
Cited by 209
Related Papers
Hyperactivating EZH2 to augment H3K27me3 levels in regulatory T cells enhances immune suppression by driving early effector differentiation
|Cell Reports|2024|19
Increased EZH2 function in regulatory T cells promotes their capacity to suppress autoimmunity by driving effector differentiation prior to activation
|bioRxiv (Cold Spring Harbor Laboratory)|2024|1
Epigenetically regulated p53 activity maintains intestinal regulatory T cell identity to prevent inflammation
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0